|
The real performance of a regulatory briefing book is not measured by page count or polish. It is measured by how efficiently a regulatory reader can follow the logic, test it, and reach a defensible position on the sponsor’s ask.
Unfortunately, many briefing books still make the reviewer work too hard. They are organized by how teams built the data—not by how regulators make decisions. That misalignment sounds minor, but it has profound cognitive consequences. The Hidden Cost of Misalignment When a document mirrors internal development logic instead of regulatory reasoning, the reader must reverse-engineer the argument. The regulatory reader sifts through design history (“the largest study ever planned in this patient population”) to locate decision relevance. They assemble fragments of details and data to reconstruct the sponsor’s logic trail. Each mental step adds friction—time, effort, and uncertainty. The concept of friction is not to be underestimated. Legal scholar Brett Frischmann describes friction as resistance or drag built into documents used in legal and regulatory decision processes. Cass Sunstein and Richard Thaler refer to unnecessary complexity in documents as sludge—“bad friction” that drains cognitive energy and delays decisions. In regulated markets, economists have quantified these effects. Studies in The Quarterly Journal of Economics and the American Economic Review show that even modest “choice frictions” in Medicare decisions significantly slow and distort judgments. The parallel for regulatory writing is direct: when reasoning is hard to trace, decision friction rises. I often tell clients that their briefing book delivers information but fails to deliver understanding. Common Patterns of Friction
Tables without interpretive anchors that leave reviewers to construct meaning. Massive appendices meant to prove thoroughness rather than aid reasoning. Each of these choices forces reviewers into reconstruction mode. They also trigger what cognitive-load theorists call the split-attention effect—when information that must be mentally integrated is physically separated across pages, tables, or sections. John Sweller’s research in applied cognitive psychology shows that split attention increases working-memory load, slows comprehension, and makes readers less confident in their conclusions. In briefing books, the effect appears when a data table sits ten pages from its interpretation or when related safety and efficacy evidence live in separate silos. The reader’s mind does the integration work the document should have done. And when reviewers must reconstruct logic, decision friction increases and confidence declines. Reviewers start to question not only the data, but the sponsor’s grasp of its own argument. A document that cannot show its reasoning clearly invites more information requests, longer review cycles, and less trust in sponsor judgment. The Decision Pathway Decision-enabling design exists to solve this exact problem. My vision of information design reorganizes briefing content around the decision pathway—the same mental sequence reviewers follow when testing an argument: Issue → Evidence → Interpretation → Position → Request This sequence is not arbitrary. It mirrors both the FDA Benefit–Risk Framework (issues → evidence → appraisal → conclusion) and the structure used in legal briefs (Issue → Rule → Application → Conclusion). Across disciplines, this logic flow has proven to reduce cognitive friction and increase confidence in reasoning. When that sequence is built into the structure, reviewers stop searching for logic and start evaluating reasoning. That shift—from retrieval to evaluation—is the defining mark of a well-designed briefing book. The Shift: From Information Display to Decision Design Teams often assume that completeness equals clarity. It doesn’t. Regulatory readers don’t reward density—they reward traceable reasoning. A decision-enabling design builds its logic trail around the reviewer’s task. Each section of the book should answer one implicit question: What decision does this content support, and what evidence makes it reasonable? When that sequence is visible, reviewers stay oriented. When it’s hidden, they reconstruct it—usually with lower confidence and more questions. The Hallmarks of Decision-Enabling Design A. Purpose-Anchored Structure Each major section begins with the So what?—why the issue matters and what decision is needed now. This tells reviewers not just what they’re reading, but why it matters. B. Progressive Disclosure Information flows from summary → key evidence → traceable detail. Reviewers can engage at any level of depth without losing sight of the reasoning line. C. Decision Cues at the Point of Use Tables and figures are placed where the decision occurs—not buried in appendices. Each display answers a single regulatory question and closes the loop with interpretation, not adjectives. The Result: Cognitive Efficiency, Not Rhetorical Flourish When design mirrors the decision process, cognitive load drops. Readers no longer have to infer your logic; they can inspect it. Review becomes faster, more confident, and less adversarial. That is the quiet power of decision-enabling design: the approach turns information into defensible reasoning—and does so on the regulatory reader’s terms. The Takeaway A decision-enabling briefing book doesn’t argue harder. It argues smarter. It lets structure do the heavy lifting and keeps reasoning in full view. When regulatory teams master this design discipline, meetings change. Regulatory readers spend less time asking “Where does this fit?” and more time discussing “What does this mean for the development program, the patient and the label?” That’s the point—clarity that enables decision. Join the conversation on LinkedIn: https://www.linkedin.com/pulse/decision-enabling-design-how-briefing-books-should-think-cuppan-3pa7c
0 Comments
Leave a Reply. |
AuthorGregory Cuppan is the Managing Principal of McCulley/Cuppan Inc., a group he co-founded. Mr. Cuppan has spent 30+ years working in the life sciences with 20+ years providing consulting and training services to pharmaceutical and medical device companies and other life science enterprises. Archives
December 2025
Categories |
RSS Feed